| Product Name |
Fulvestrant Inhouse Impurity 15 / (7R,8R,9S,13R,14S,17S)-7-(9-((9-((7R,8S,9S,13R,14S,17S)-3-hydroxy-13,17-dimethyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)nonyl)sulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydro-13H-cyclopen
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
N/A |
| Catalog Number |
GS.47.FUL.45 |
| Chemical Name/Synonyms |
(7R,8R,9S,13R,14S,17S)-7-(9-((9-((7R,8S,9S,13R,14S,17S)-3-hydroxy-13,17-dimethyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-7-yl)nonyl)sulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydro-13H-cyclopenta[a]phenanthrene-3,13,17-triol |
| Molecular Weight |
843.31 |
| Molecular Formula |
C54H82O5S |
| Purity |
NLT 95 % |
| Applications |
It is an impurity of Fulvestrant which is used to treat breast cancer |
| Inventory Status |
customized
|